Though T cell-derived EVs are always recognized as antitumor NPs exhibiting a tumor suppression effect, it has been reported that EVs from exhausted CD8+ T cells assist tumor progression indirectly by impairing the proliferation of normal CD8+ T cells. This evidence concerns the gene CD8A and neoplasm.